ABT NYSE
Abbott Laboratories
1W: +0.7%
1M: +2.1%
3M: -4.5%
YTD: -16.5%
1Y: -18.7%
3Y: +10.8%
5Y: -6.8%
$103.10
-1.78 (-1.70%)
After Hours: $103.28 (+0.18, +0.17%)
Weekly Expected Move ±3.5%
$96
$100
$104
$107
$111
Credit Risk of going bust: lower than 80% of companies Debt: 15.2% of company value Bonds: $1.35B held by 411 funds, 57 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.24 (down 99%), Abbott Laboratories would be worth roughly what it owes.
Total debt $32.61B against a stock market value of $181.48B.
Distance to default 9.66 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $17.81B (short-term plus half of long-term), stock volatility 27.4%; Altman Z 3.28. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.24 (down 99%), Abbott Laboratories would be worth roughly what it owes.
Total debt $32.61B against a stock market value of $181.48B.
Distance to default 9.66 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $17.81B (short-term plus half of long-term), stock volatility 27.4%; Altman Z 3.28. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.22
Neutral
2 bullish
1 neutral
1 bearish
Articles (24h)
4
Hourly Sentiment (24h)
0.00
Neutral
7 bullish
6 neutral
7 bearish
Articles (7d)
20
Daily Sentiment (7 Days)
Articles (100)
Abbott downgraded at Argus on guidance cut
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
Is Most-Watched Stock Abbott Laboratories (ABT) Worth Betting on Now?
Abbott Laboratories $ABT Shares Purchased by Evergreen Capital Management LLC
This Dividend King Just Announced Great News for Investors
Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?
Abbott Laboratories $ABT Shares Sold by Axxcess Wealth Management LLC
Abbott's Q3 Earnings Call Focuses on Nutrition Spin-Off and Outlook
Cologuard Is Working—So Why Isn’t Abbott Stock?
Abbott: 3 Key Takeaways for Long-Term Investors
Abbott (ABT) Q3 2026 Earnings Call Transcript
Midday Need to Know: Putin signals Ukraine talks, Abbott cuts outlook & more
Biggest stock movers Wednesday: NFLX, SPCX, ABT, and more
Pre-Markets Up on Cooling Metrics, Decent Q3 Reports
Abbott slips after cutting 2026 growth outlook amid nutrition spinoff
Abbott (ABT) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
ABT Stock Down Post Q3 Earnings Miss, Revenues Rise Y/Y, Margins Up
Abbott to separate its nutrition unit as a public firm
Abbott (ABT) Misses Q3 Earnings Estimates
Abbott Q3 results top estimates, keeps 2026 EPS forecast unchanged
XLV touches a new high, hitting overbought territory
Here are the major earnings before the open Wednesday
Abbott Q3 preview: What to expect
DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study
The Zacks Analyst Blog Highlights Abbott Laboratories, Johnson & Johnson, Stryker, Waste Management and Republic Services
Goldman's defensive stocks with quality-growth characteristics
Ken Griffin Increased His Position in This Dividend King by a Whopping 546% in Q2. Here's Why It's Still a Buy.
Earnings Week Ahead: TSLA, META, NFLX, CMCSA, GE, GM, T, VZ, and more
Earnings Scoreboard: 83% of S&P 500 early reporters beat EPS estimates as Y/Y profit growth hits 23 firms
I Just Invested $4,600 Across 3 Top Dividend Stocks. Here’s What I’m Loading Up on Right Now.
Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle
Abbott Laboratories $ABT Stock: Banque Pictet & Cie SA Increases Stake
Catalyst Watch: Meta earnings, Kroger event, and Black Monday turns 39
Countdown to Abbott (ABT) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Reasons to Add STE Stock to Your Portfolio Right Now
Haemonetics Gains 149.3% in a Year: What's Driving the Rally?
Is it Apt to Retain Medtronic Stock in Your Portfolio Now?
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?
Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now?
Abbott Laboratories $ABT Stock: Krilogy Financial LLC Increases Stake
Bet on These Healthcare ETFs to Benefit From the Aging US Population
The Market Is Flashing Warning Signals Not Seen in Years. Here’s Why I Just Bought 3 of SCHD’s Dividend Kings.
Is This the Right Time to Retain Omnicell Stock in Your Portfolio?
Should You Add Abbott Stock to Your Portfolio Ahead of Q3 Earnings?
Abbott Laboratories $ABT Stock: Perpetual Ltd Trims Stake
Want Passive Income for Life? Here Are 2 Dividend Stocks to Buy and Never Sell
Abbott (ABT) Gains As Market Dips: What You Should Know
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?
AbbVie's Dividend Yield Is at Its Lowest Level Since 2018. Here's Why the Stock Is Still a Great Pick for Income Investors Anyway.
How Much Would You Need to Invest in These 5 Pharma Stocks to Earn $1,000 a Month in Dividends?
History Says Abbott Stock Could More Than Double by 2036. Here’s Why I Just Added It to My Portfolio.
8,647 Abbott Laboratories $ABT Shares Sold by CoreCap Advisors LLC
10,431 Abbott Laboratories $ABT Shares Purchased by Farther Finance Advisors LLC
Catalyst watch: Big bank earnings, CPI, and the Paris Auto Show
Cancer Stocks to Consider as Oncology Innovation Accelerates
Is it the Right Time to Hold TNDM Stock in Your Portfolio?
Dividend Roundup: Starbucks, Pfizer, Micron, AbbVie, and more
Bell Asset Management Ltd Sells 15,436 Shares of Abbott Laboratories $ABT
Trump's top August holdings fall short of bullish Quant ratings
Is it the Right Time to Add Phibro Stock to Your Portfolio?
Trump's top August trades include Meta, SpaceX, AT&T buys, among others
Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Stryker, Abbott among Overweight ideas as Barclays turns bullish on MedTech
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note
Park National Corp OH Sells 10,269 Shares of Abbott Laboratories $ABT
Eastern Bank Decreases Stake in Abbott Laboratories $ABT
The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health Companies
Moderna, Illumina lead healthcare gains in September as medtech drags
Abbott Laboratories $ABT Stock Sold by CX Institutional
How to Create a Million-Dollar Stock Portfolio
DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care
4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike
These 3 Dividend Stocks Yield Less Than 10-Year Treasuries Over 5%. Here's Why They Are Better Buys Anyway.
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?
Abbott (ABT) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Abbott launches "SimpleScreen" blood test to expand cancer screening
NVST vs. ABT: Which Stock Is the Better Value Option?
Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note
Want a Portfolio That Pays You $1,000 a Month in Passive Income? This Dividend ETF Could Get You There.
MiniMed a new Buy at Truist on turnaround following Medtronic split
GRAIL sets new 52-week high as FDA panel backs cancer test
Envestnet Asset Management Inc. Sells 1,228,773 Shares of Abbott Laboratories $ABT
Abbott Laboratories $ABT Shares Sold by Engineers Gate Manager LP
Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Abbott partners with Berry Street to provide nutrition coaching to Lingo users
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
3 High-Yielding Dividend Stocks That Are No-Brainer Buys for Retirees and Risk-Averse Investors
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth
Will Boston Scientific's Upcoming Launches Fuel the Next Growth Phase?
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Nykredit A S Purchases New Holdings in Abbott Laboratories $ABT
3 Dividend Stocks to Buy and Hold for 10 Years
10 large and mega-cap U.S. healthcare stocks with the weakest momentum grades
Trump administration is said to weigh allowing most pharma licensing deals with China
Why Wall Street Is Becoming Even More Bullish About This Dividend King
Looming biosimilar void risks $189B in lost U.S. healthcare savings: report
Abbott Laboratories declares $0.63 dividend
Boston Scientific downgraded at Citi on increasing competition, cyberattack fallout